claim: low-density lipoprotein cholesterol levels are associated with greater clinical outcomes in covid-19
evidence_1: non-survivors had lower total cholesterol (tc) and low-density lipoprotein cholesterol (ldl-c) levels during the entire course of the disease with complete resolution among survivors.